L-Ergothioneine.com Editorial Team
Published by an independent editorial team. Individual medical or scientific credentials are not claimed; named reviewers appear only after their role is documented.
About the publication →The independent guide to L-ergothioneine
Learn what ergothioneine is, why researchers are studying it in healthy aging, where it occurs naturally, what human studies show, and how to evaluate supplements.
In 60 seconds
Ergothioneine is a naturally occurring sulfur-containing amino-acid derivative found particularly in mushrooms and certain foods. Humans obtain it through diet and possess a specialized transporter that concentrates it in selected cells and tissues.
Primary sources: transporter discovery ↗ · human uptake study ↗ · dietary-source analysis ↗
Human research is developing. This guide shows where the science is promising—and where confident claims move beyond the evidence.
Read the complete explanation →Who, how and why
Health information should make its authorship, method, commercial relationships and medical scope easy to inspect.
Published by an independent editorial team. Individual medical or scientific credentials are not claimed; named reviewers appear only after their role is documented.
About the publication →Claims are classified by study design and checked against primary or authoritative sources. AI may assist organization and formatting, but does not independently approve health claims.
Read the editorial policy →No affiliate product links are active at launch. Future commissions, samples, sponsorships or direct financial relationships will be labeled and kept separate from evidence assessments.
Read the disclosure →This site does not diagnose, treat or provide individualized medical advice. Discuss supplement decisions with a qualified healthcare professional who knows your circumstances.
Read the medical disclaimer →Registry snapshot
Process statuses are not evidence ratings. Final classifications appear only after the research brief and human approval are complete.
Two randomized trials and prospective cohorts are undergoing adversarial review.
View registry statusEarly controlled signals are being checked for outcome selection and replication.
View registry statusHuman associations and preclinical lifespan findings are being separated.
View registry statusMechanistic plausibility has not yet passed the full review process.
View registry statusNo rating will be assigned before a complete evidence brief.
View registry statusProduct-specific evidence requires attribution and independence checks.
View registry statusWhy ergothioneine is unusual
Established transport biology on the left; open clinical questions on the right.
Ergothioneine enters the human system mainly through diet.
Mushrooms are leading sources; content varies by species and method.
SLC22A4—also called ETT or OCTN1—supports cellular uptake.
Distribution is shaped by transporter expression, not simple diffusion.
Mechanistic plausibility must be followed by controlled human outcomes.
Food sources
Oyster, lion’s mane, shiitake, porcini and other mushrooms appear in primary food analyses, but values vary by species, growing conditions, sample preparation and measurement method.
See foods highest in ergothioneine →Quantitative values publish only after unit and citation verification.
Latest human research
Finding: Supplementation increased plasma ergothioneine, but the primary composite-memory outcome did not show a significant treatment effect at 16 weeks. Selected secondary, subjective, or time-by-treatment signals were reported.
Important limitation: The primary cognitive outcome was null; an early within-group signal was not sustained; several positive findings were secondary, subjective, per-protocol, or within-group results.
Finding: The ergothioneine group improved on a learning assessment and showed a different neurofilament-light trajectory than placebo; routine blood, kidney and liver safety markers did not change.
Important limitation: Very small pilot sample; exploratory outcomes; not adequate to establish prevention or treatment of cognitive decline.
Finding: Higher serum ergothioneine was associated with lower incidence of all-cause dementia, Alzheimer’s disease, and non-Alzheimer dementia after multivariable adjustment.
Important limitation: Observational exposure cannot establish causation or show that supplementation prevents dementia; residual confounding and reverse causation remain possible.
Supplement buyer’s guide
We do not rank products before verifying labels, prices, testing documentation and conflicts. Start with the fields that make a comparison reproducible.
See the buyer’s guide →